Illinois Retina Associates
Joliet, Illinois 60435
1 studies enrolling now · 15 studies all time
What they study most
Age Related Macular Degeneration, Age-Related Macular Degeneration, Choroidal Neovascularization, Diabetic Macular Edema, Diabetic Retinopathy, Macular Degeneration, Neovascular Age-Related Macular Degeneration, Pain, Proliferative Diabetic Retinopathy, Proliferative Vitreoretinopathy, Wet Macular Degeneration
Studies at this site
- A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003) — Recruiting now
- Extension Study for the Port Delivery System With Ranibizumab (Portal) — Recruiting now
- A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME — Running, not enrolling
- A Multicenter, Randomized Study in Participants With Diabetic Retinopathy Without Center-involved Diabetic Macular Edema To Evaluate the Efficacy, Safety, and Pharmacokinetics of Ranibizumab Delivered Via the Port Delivery System Relative to the Comparator Arm — Completed
- The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy — Completed
- A Phase III Study to Evaluate the Port Delivery System With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration — Completed
- Study of the Efficacy and Safety of the Ranibizumab Port Delivery System for Sustained Delivery of Ranibizumab in Patients With Subfoveal Neovascular Age-Related Macular Degeneration — Completed
- Treatment for CI-DME in Eyes With Very Good VA Study — Completed
- Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema — Completed
- Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial — Completed
- Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study — Completed
- A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin) — Completed
- Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy — Completed
- Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema — Completed
- Patient Assessment of Topical Anesthetic Effectiveness for Intravitreal Injections — Completed